Skip to main content
. 1998 May 30;316(7145):1648–1654. doi: 10.1136/bmj.316.7145.1648

Table 2.

Model 1: differences in outcome between four antibiotic strategies for eradication of Helicobacter pylori

Strategy Cost (£) % Eradication of H pylori Cost of successful eradication (£) Incremental cost of strategy 4 to strategies 1, 2, or 3 (£)* Time (years) for future relapse treatment costs to equal incremental cost of strategy 4
Not discounted Discounted
1
OAM 20.20 85 23.76 363.58 6.5 7.9
2
OCM 29.20 91 32.08 589.59 10.6 15.7
3
OAM+UBT+OCM 55.38 94 58.6 3 326.57 5.9 6.9
4
OCM+UBT+OCM 62.63 97 64.78 Base Base Base

OAM=omeprazole, amoxycillin, and metronidazole; OCM=omeprazole, clarithromycin, and metronidazole; UBT=13C-urea breath test.  

*

Additional cost of obtaining 1% increase in eradication rate.  

Incremental cost of strategy 4 divided by annual cost (£55.60) of relapse treatment.  

Future costs incurred after first year of eradication treatment discounted at 6% per year.